HHLR ADVISORS, LTD. - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 157 filers reported holding AKERO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.5%.

Quarter-by-quarter ownership
HHLR ADVISORS, LTD. ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,808,441
+8.3%
273,0020.0%0.31%
+13.7%
Q2 2023$12,746,463
+12.7%
273,002
-7.6%
0.27%
+35.5%
Q1 2023$11,305,907
-34.6%
295,502
-6.3%
0.20%
-45.2%
Q4 2022$17,289,510
-25.3%
315,502
-53.6%
0.36%
-40.1%
Q3 2022$23,154,000
+80.3%
680,000
-50.0%
0.61%
+121.5%
Q2 2022$12,843,000
-33.4%
1,359,052
-0.0%
0.28%
-31.8%
Q1 2022$19,286,000
-32.9%
1,359,1520.0%0.40%
-9.2%
Q4 2021$28,746,000
-16.5%
1,359,152
-11.8%
0.44%
-1.3%
Q3 2021$34,429,000
-16.2%
1,540,465
-7.0%
0.45%
+6.4%
Q2 2021$41,102,000
-14.5%
1,656,6730.0%0.42%
-10.9%
Q1 2021$48,060,000
+12.4%
1,656,6730.0%0.48%
+39.7%
Q4 2020$42,742,000
-16.2%
1,656,6730.0%0.34%
-11.9%
Q3 2020$51,009,000
+93.7%
1,656,673
+56.8%
0.39%
+60.2%
Q2 2020$26,332,000
+39.4%
1,056,673
+18.6%
0.24%
-5.5%
Q1 2020$18,893,000
-4.5%
891,2010.0%0.26%
+3.7%
Q4 2019$19,780,000
+16.0%
891,201
+18.9%
0.25%
+5.1%
Q3 2019$17,049,000
+109.5%
749,424
+76.3%
0.23%
+28.6%
Q2 2019$8,139,000425,0000.18%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
University of Wisconsin Foundation 103,816$5,251,0136.02%
Boxer Capital, LLC 1,676,733$84,809,1554.52%
Redmile Group, LLC 1,769,684$89,510,6174.26%
Ghost Tree Capital, LLC 250,000$12,645,0004.16%
Logos Global Management LP 600,000$30,348,0004.05%
COMMODORE CAPITAL LP 565,000$28,577,7003.34%
Yiheng Capital Management, L.P. 1,221,674$61,792,2713.15%
SILVERARC CAPITAL MANAGEMENT, LLC 200,000$10,116,0003.07%
Atlas Venture Life Science Advisors, LLC 359,251$18,170,9152.81%
Perceptive Advisors 1,619,425$81,910,5172.73%
View complete list of AKERO THERAPEUTICS INC shareholders